Clinical Research Directory
Browse clinical research sites, groups, and studies.
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
Sponsor: Médecins du Monde
Summary
Implementation and evaluation of a distribution program for low dead-space syringes/needles (LDSS/N) in Armenia, Georgia, and Tanzania, Egypt, Nigeria, Vietnam, India, Ukraine, and South Africa. This study aims to generate evidence on best practice LDSS/N distribution programs which will enhance acceptability and sustain high levels of LDSS/N uptake. People who inject drugs and access needle and syringe programs will be invited to attend up to three focus group discussion rounds (with 25 participants in each focus group round) to inform and provide feedback on a concurrent distribution program of LDSS/N. Throughout distribution, a cohort study will be run alongside distribution with 240 participants enrolled per country (with the exception of Nigeria, where 480 participants will be recruited) who will undergo HIV and HCV testing and answer surveys on their sociodemographic and behavioral status. Key informant interviews will also be held with participating staff and stakeholders to evaluate the feasibility and acceptability of this program. Primary outcomes assessed through this study include 1) community values and preferences for LDSS/N, 2) barriers and facilitators to accessing LDSS/N, 3) feasibility and effectiveness of the distribution program on increasing LDSS/N uptake, 4) model the potential public health impact and cost effectiveness of LDSS/N distribution in this setting.
Official title: Implementing a Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries: a Process and Outcome Evaluation
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2400
Start Date
2024-09-13
Completion Date
2026-12
Last Updated
2025-10-01
Healthy Volunteers
Yes
Interventions
Low dead-space syringes/needles
LDSS/N are a type of syringe/needle which retains less residual blood following an injecting event when compared to HDSS/N.
Hepatitis C Antibody Rapid Diagnostic Test
Administered up to 4 times, at baseline, 6-months, 12-months, and 18-months
HIV rapid Diagnostic Test
Administered up to 4 times, at baseline, 6-months, 12-months, and 18-months
Locations (9)
Real World Real People
Yerevan, Armenia
Step to Future
Gori, Georgia
New Vector
Rustavi, Georgia
Hepa+
Tbilisi, Georgia
Mukikute
Dar es Salaam, Tanzania
Peer 2 Peer
Dar es Salaam, Tanzania
Yovaribe
Ilala, Tanzania
Mefada
Kinondoni, Tanzania
STEPS Tanzania
Ubungo, Tanzania